Charles River Laboratories International, Inc. (CRL)
358.81
+1.54
(+0.43%)
USD |
NYSE |
Oct 27, 16:00
358.81
0.00 (0.00%)
After-Hours: 17:20
Charles River Laboratories International Enterprise Value : 19.92B for Oct. 26, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 26, 2026 | 19.92B |
| October 23, 2026 | 19.35B |
| October 22, 2026 | 19.08B |
| October 21, 2026 | 19.33B |
| October 20, 2026 | 17.92B |
| October 19, 2026 | 17.19B |
| October 16, 2026 | 17.19B |
| October 15, 2026 | 17.48B |
| October 14, 2026 | 17.28B |
| October 13, 2026 | 17.14B |
| October 12, 2026 | 17.27B |
| October 09, 2026 | 17.27B |
| October 08, 2026 | 17.09B |
| October 07, 2026 | 17.20B |
| October 06, 2026 | 17.42B |
| October 05, 2026 | 17.70B |
| October 02, 2026 | 16.72B |
| October 01, 2026 | 16.56B |
| September 30, 2026 | 16.95B |
| September 29, 2026 | 16.99B |
| September 28, 2026 | 16.93B |
| September 25, 2026 | 16.84B |
| September 24, 2026 | 16.92B |
| September 23, 2026 | 16.10B |
| September 22, 2026 | 16.47B |
| Date | Value |
|---|---|
| September 21, 2026 | 16.18B |
| September 18, 2026 | 16.14B |
| September 17, 2026 | 16.31B |
| September 16, 2026 | 15.92B |
| September 15, 2026 | 15.89B |
| September 14, 2026 | 15.90B |
| September 11, 2026 | 16.15B |
| September 10, 2026 | 15.90B |
| September 09, 2026 | 16.15B |
| September 08, 2026 | 16.27B |
| September 04, 2026 | 16.64B |
| September 03, 2026 | 16.87B |
| September 02, 2026 | 16.79B |
| September 01, 2026 | 16.34B |
| August 31, 2026 | 16.62B |
| August 28, 2026 | 16.78B |
| August 27, 2026 | 17.01B |
| August 26, 2026 | 16.95B |
| August 25, 2026 | 17.07B |
| August 24, 2026 | 17.12B |
| August 21, 2026 | 16.96B |
| August 20, 2026 | 16.78B |
| August 19, 2026 | 16.71B |
| August 18, 2026 | 16.19B |
| August 17, 2026 | 16.55B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Fortrea Holdings, Inc. | 3.215B |
| IQVIA Holdings, Inc. | 59.33B |
| Medpace Holdings, Inc. | 18.35B |
| Champions Oncology, Inc. | 74.82M |
| Avantor, Inc. | 15.09B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.76M |
| Revenue (Quarterly) | 1.004B |
| Total Expenses (Quarterly) | 1.006B |
| EPS Diluted (Quarterly) | -0.0309 |
| Gross Profit Margin (Quarterly) | 36.29% |
| Profit Margin (Quarterly) | -0.08% |
| Earnings Yield | -1.35% |
| Operating Earnings Yield | 3.08% |
| Normalized Earnings Yield | 0.5243 |